Sarah Anand, MD

University of Michigan
Blood and Marrow Transplantation Program
Ann Arbor, MI
USA Papers:
356 Serial Biomarker Monitoring Early after HCT Identifies Different Risks for Relapse and Graft-Vs-Host Disease